SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Adagio Medical Holdings, (ADGM) — Dec 10, 2025

Adagio Medical Holdings, Inc.
Date: Dec. 10, 2025 · CIK: 0002006986 · Accession: 0001104659-25-119990

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-291741

Date
December 10, 2025
Author
Deborah Kaster
Form
CORRESP
Company
Adagio Medical Holdings, Inc.

Letter

A dagio Medical Holdings , I NC.

26051 Merit Circle, Suite 102

Laguna Hills, CA 92653

December 10, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: A dagio Medical Holdings, Inc.

Registration Statement on Form S-3 (File No. 333-291741)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the " Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-291741) (the " Registration Statement ") to become effective on December 12, 2025, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Registrant hereby authorizes each of Eric Blanchard and Paul Alexander of Cooley LLP to make such a request on its behalf.

Once the Registration Statement has been declared effective, please confirm that event with Eric Blanchard of Cooley LLP, counsel to the Registrant, at (617) 937-2445 or eblanchard@cooley.com, or in his absence, Paul Alexander, at (202) 776-2118 or palexander@cooley.com.

[Signature page follows]

Very truly yours,
Adagio Medical Holdings, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 A dagio
Medical Holdings , I NC.

 26051 Merit Circle, Suite 102

 Laguna Hills, CA 92653

 December 10, 2025

 Via EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Re:
 A dagio Medical Holdings, Inc.

 Registration Statement on Form S-3 (File No. 333-291741)

 Request for Acceleration of Effective Date

 Ladies and Gentlemen:

 In accordance with Rule 461 under the Securities Act of 1933, as amended,
the undersigned registrant (the " Registrant ") hereby requests that the Securities and Exchange Commission (the
" Commission ") take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File
No. 333-291741) (the " Registration Statement ") to become effective on December 12, 2025, at 4:00 p.m. Eastern
Time, or as soon thereafter as is practicable, or at such other time as the Registrant or its legal counsel, Cooley LLP, may request by
telephone to the staff of the Commission. The Registrant hereby authorizes each of Eric Blanchard and Paul Alexander of Cooley LLP to
make such a request on its behalf.

 Once the Registration Statement has been declared effective, please
confirm that event with Eric Blanchard of Cooley LLP, counsel to the Registrant, at (617) 937-2445 or eblanchard@cooley.com, or in his
absence, Paul Alexander, at (202) 776-2118 or palexander@cooley.com.

 [Signature page follows]

 Very truly yours,

 Adagio Medical Holdings, Inc.

 By:
 /s/ Deborah Kaster

 Deborah Kaster

 Chief Financial Officer and Chief Business Officer

 cc:
 Todd Usen, Adagio Medical Holdings, Inc.

 Eric Blanchard, Cooley LLP

 Paul Alexander, Cooley LLP

 Signature Page to Company Acceleration Request
– S-3